News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year20272026202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search An article analyses the transformation of Vall d’Hebron to tackle the COVID-19 pandemic 29/07/2022 ESPID has awarded a study in which Vall d'Hebron has participated 13/06/2022 A publication of Vall d'Hebron, awarded by 'Anales de Pediatría' 02/06/2022 Blood testosterone as a COVID-19 survival marker in men 19/04/2022 Almost 20% of patients with headache during COVID-19 develop chronic daily headache 23/02/2022 Hepatology is the Service with the highest participation in liver disease trials 22/02/2022 A program to support patients with primary immunodeficiencies at Vall d'Hebron expands to Bellvitge Hospital 19/01/2022 Vall d'Hebron, a reference in care and research in enterovirus infection 29/12/2021 Bufa la Bombolla returns for primary immunodeficiency research 29/11/2021 Vall d'Hebron participates in an international study that associates new genetic and immunological defects with severe COVID-19 18/08/2021 Vall d’Hebron has reached a record number of clinical trials despite the pandemic 19/05/2021 Genetic variations in testosterone receptor predispose to sever COVID-19 in men 22/03/2021 Published the results of the Vall d’Hebron study, which shows that minors are low transmitters of SARS-CoV-2 15/03/2021 One in four patients admitted to the ICU with COVID-19 suffers a thrombosis, which in many cases is asymptomatic 12/01/2021 Vall d’Hebron shows that ECMO can save the life of the most severe COVID-19 patients 15/10/2020 Campus Vall d'Hebron signs a Prime Site Agreement with IQVIA, the world's largest clinical trial management company 23/04/2018 Pagination « First First page ‹ Previous Previous page 1 2 3 4 5 6